With cervical cancer being the common cancer and on average affecting women at 47 years, many school-going girls have different perceptions of and attitudes to the HPV vaccination, leading to delayed or no acceptance of the vaccine. Hence, there is a need to assess the quality and quantity of knowledge and attitudes on the acceptability of HPV vaccination among primary school girls to plan targeted interventions to prevent this condition in Uganda.
This cross-sectional study determined the knowledge, attitudes to, and acceptability of HPV vaccination among primary school girls aged 9 years and older in Minakulu sub-county, Northern Uganda. The sample size was determined using the formula of Kish (1965) . Systematic sampling of 415 pupils and five purposively selected key informant interviews were conducted using semistructured questionnaires and the key informant checklist. Quantitative data were analyzed using SPSS 16.0 (SPSS Inc., Chicago, Illinois, USA), whereas qualitative data were analyzed manually by direct content analysis of themes. The study was approved by the Institutional Review Committee of Gulu University (GU/IRC/14/03/13).
Privacy and confidentiality of information and voluntary assent/withdrawal were allowed. Consent was sought from parents, guardians, and teachers for pupils younger than 14 years of age.
All participants were from a mixed school setting. Of the 415 respondents, the majority were between 13 and 16 years of age [282 (68.0%); mean 13±1.66 years at 95% confidence interval; age ranged from 9 to 20 years]. There was a statistically significant association between respondents' school setting and acceptability of HPV vaccination (w 2 = 27.111, P = 0.003, 95% confidence interval). There was no statistically significant association between age, religion, tribe, residents, and acceptability of HPV vaccination.
Although cervical cancer remains a public health priority in Uganda, this study indicated misconceptions about cervical cancer and the HPV vaccine; nearly half of the respondents believed that the HPV vaccine was harmful to their body, a third had never been vaccinated with the HPV vaccine, less than 10% disagreed when asked whether cervical cancer affects only females, whereas others were not sure of the possible outcomes. A good number did not know whether HPV was sexually transmitted and whether the cancer affected the cervix. Two-fifth of the respondents were not sure about the site of administration of the HPV vaccine; yet, over half of the respondents wished to seek this information from their teachers, who reported to have inadequate knowledge.
Although HPV vaccination was highly acceptable, with positive attitudes among primary school girls, there were still mixed reactions and wrong perceptions about the intervention. Although the majority stated that they would accept and recommend the vaccine, the majority had not been vaccinated. However, most respondents had a general belief that vaccines prevent diseases, based on an earlier PATH Ugandan survey. Although this study shows that people generally supported HPV vaccination, respondents emphasized the need to carry out massive sensitization as vaccination for primary prevention of cervical cancer is generally a new concept, a fact that could explain the low level of knowledge found.
Attitudes and acceptability to HPV vaccination were high, although only a few respondents had been vaccinated. There was still limited knowledge and misconceptions about cervical cancer and the HPV vaccine in the communities. There is a huge need for massive sensitization of the population at risk to increase vaccine uptake.
